Authors:
VONDERHEID EC
ZHANG Q
LESSIN SR
POLANSKY M
ABRAMS JT
BIGLER RD
WASIK MA
Citation: Ec. Vonderheid et al., USE OF SERUM-SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS TO MONITOR THE PROGRESSION OF CUTANEOUS T-CELL LYMPHOMA, Journal of the American Academy of Dermatology, 38(2), 1998, pp. 207-220
Authors:
MARKS DI
VONDERHEID EC
KURZ BW
BIGLER RD
SINHA K
MORGAN DA
SUKMAN A
NOWELL PC
HAINES DS
Citation: Di. Marks et al., ANALYSIS OF P53 AND MDM-2 EXPRESSION IN 18 PATIENTS WITH SEZARY-SYNDROME, British Journal of Haematology, 92(4), 1996, pp. 890-899
Authors:
REUBEN JM
VONDERHEID EC
LEE BN
BIGLER RD
LESSIN SR
PARKER K
Citation: Jm. Reuben et al., DETECTION OF CIRCULATING NEOPLASTIC T-CELLS IN PATIENTS WITH SEZARY-SYNDROME AND ERYTHRODERMIC MYCOSIS-FUNGOIDES BY 3-COLOR IMMUNOFLUORESCENCE FLOW-CYTOMETRY, Blood, 88(10), 1996, pp. 3478-3478
Authors:
WASIK MA
VONDERHEID EC
BIGLER RD
MARTI R
LESSIN SR
POLANSKY M
KADIN ME
Citation: Ma. Wasik et al., INCREASED SERUM CONCENTRATION OF THE SOLUBLE INTERLEUKIN-2 RECEPTOR IN CUTANEOUS T-CELL LYMPHOMA - CLINICAL AND PROGNOSTIC IMPLICATIONS, Archives of dermatology, 132(1), 1996, pp. 42-47
Authors:
WASIK MA
VONDERHEID EC
BIGLER RD
MARTL R
LESSIN S
POLANSKY M
Citation: Ma. Wasik et al., INCREASED SERUM CONCENTRATION OF THE SOLUBLE INTERLEUKIN-2 RECEPTOR IN CUTANEOUS T-CELL LYMPHOMA - CLINICAL AND PROGNOSTIC IMPLICATIONS, Laboratory investigation, 72(1), 1995, pp. 122-122
Citation: Rd. Bigler et al., CD40L IS EXPRESSED ON ACTIVATED CELLS OF SEZARY PATIENTS WITH ELEVATED IGE, The FASEB journal, 8(5), 1994, pp. 10001006-10001006
Authors:
VONDERHEID EC
BIGLER RD
GREENBERG AS
NEUKUM SJ
MICAILY B
Citation: Ec. Vonderheid et al., EXTRACORPOREAL PHOTOPHERESIS AND RECOMBINANT INTERFERON ALFA-2B IN SEZARY-SYNDROME - USE OF DUAL MARKER LABELING TO MONITOR THERAPEUTIC RESPONSE, American journal of clinical oncology, 17(3), 1994, pp. 255-263
Authors:
ESFAHANI M
BIGLER RD
ALFIERI JL
LUNDKATZ S
BAUM JD
SCERBO L
Citation: M. Esfahani et al., CHOLESTEROL REGULATES THE CELL-SURFACE EXPRESSION OF GLYCOPHOSPHOLIPID-ANCHORED CD14 ANTIGEN ON HUMAN MONOCYTES, Biochimica et biophysica acta, 1149(2), 1993, pp. 217-223
Citation: M. Esfahani et al., EFFECT OF LOVASTATIN ON CELL-SURFACE EXPRESSION OF FC-RECEPTORS OR CD14 ANTIGEN IN HUMAN MONOCYTES, Biochemical pharmacology, 46(12), 1993, pp. 2333-2336